LFST (LifeStance Health Group) Inventory-to-Revenue: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LFST LifeStance Health Group Inc LFST
54 GF Score
Price $10.81
GF Value $8.31
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group Inventory-to-Revenue?

LifeStance Health Group LFST -1.73% 54 Inventory-to-Revenue is 0.00 as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 54/100 and a GF Value™ of $8.31 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LifeStance Health Group's Average Total Inventories for the quarter that ended in Mar. 2026 was $0 Mil. LifeStance Health Group's Revenue for the three months ended in Mar. 2026 was $403 Mil. LifeStance Health Group's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.00.

LifeStance Health Group's Inventory-to-Revenue for the quarter that ended in Mar. 2026 stayed the same from Dec. 2025 (0.00) to Dec. 2025 (0.00)

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LifeStance Health Group's Days Inventory for the three months ended in Mar. 2026 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.


LifeStance Health Group  (NAS:LFST) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LifeStance Health Group's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2026 )/Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=0/267.544*365 / 4
=0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LifeStance Health Group's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2026 ) / Average Total Inventories (Q: Mar. 2026 )
=267.544 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeStance Health Group Inventory-to-Revenue Related Terms


LifeStance Health Group Inventory-to-Revenue Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group Inventory-to-Revenue Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventory-to-Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LifeStance Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LFST vs CON, BKD, OPCH: Inventory-to-Revenue Comparison

For the Medical Care Facilities subindustry, LifeStance Health Group's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeStance Health Group Inventory-to-Revenue vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's Inventory-to-Revenue falls into.


LFST
54GF Score
LifeStance Health Group Inc LFST
Inventory-to-Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LifeStance Health Group's Inventory-to-Revenue for the fiscal year that ended in Dec. 2025 is calculated as

Inventory-to-Revenue (A: Dec. 2025 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Revenue (A: Dec. 2025 )
=( (0 + 0) / 1 ) / 1424.285
=0 / 1424.285
=0.00

LifeStance Health Group's Inventory-to-Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue (Q: Mar. 2026 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2025 ) + Total Inventories (Q: Mar. 2026 )) / count ) / Revenue (Q: Mar. 2026 )
=( (0 + 0) / 1 ) / 403.476
=0 / 403.476
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Inventory-to-Revenue →
What does a Inventory-to-Revenue of 0.00 mean?
LifeStance Health Group (LFST) has a Inventory-to-Revenue of 0.00 as of Mar. 2026. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on LifeStance Health Group and its competitors.
Is LifeStance Health Group's Inventory-to-Revenue too high?
LifeStance Health Group's current Inventory-to-Revenue is 0.00. Overall, LifeStance Health Group has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Inventory-to-Revenue compare to CON and BKD?
LifeStance Health Group's Inventory-to-Revenue of 0.00 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory-to-Revenue for a Healthcare Providers & Services company?
A good Inventory-to-Revenue depends on the Healthcare Providers & Services industry context. However, Inventory-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory-to-Revenue mean?
A high Inventory-to-Revenue can signal that a stock is expensive relative to its fundamentals. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on LifeStance Health Group and its competitors. LifeStance Health Group's current Inventory-to-Revenue is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Modestly Overvalued. The stock's GF Value™ is $8.31, compared to a current price of $10.81 — trading 30.1% above its estimated fair value. The current Inventory-to-Revenue is 0.00. LifeStance Health Group's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory-to-Revenue calculated?
Inventory-to-Revenue is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Inventory-to-Revenue is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $10.81 is trading 30.1% above its estimated GF Value™ of $8.31. GuruFocus considers LifeStance Health Group to be Modestly Overvalued.

Key valuation signals for LFST:

  • Inventory-to-Revenue: 0.00
  • GF Value™: $8.31 vs. price of $10.81 (30.1% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
54GF Score

Get the complete analysis for LFST

Inventory-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.81
Price
$8.31
GF Value